Development of antiparallel-type triplex-forming oligonucleotides containing quinoline derivatives capable of recognizing a T-A base pair in a DNA duplex

Bioorg Med Chem. 2022 Oct 1:71:116934. doi: 10.1016/j.bmc.2022.116934. Epub 2022 Jul 29.

Abstract

A triplex-forming oligonucleotide (TFO) can bind to genomic DNA and inhibit the expression of genes with specific sequences. However, to date, there have been a few reports of modified bases in antiparallel TFOs that can recognize and strongly bind to T-A base pairs. In this study, we introduced several quinoline derivatives into antiparallel TFOs to develop modified bases that can recognize the T-A base pair and evaluated their ability to form triplexes and to discriminate between base pairs. The introduction of 2-acetamido-6-aminoquinoline6DAQac) into an antiparallel TFO allowed the selective recognition of a T-A base pair at both low and high salt concentrations.

Keywords: DNA nanotechnology; Gene therapy; Modified oligonucleotide; Triplex-forming oligonucleotide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Pairing
  • DNA* / metabolism
  • Molecular Structure
  • Nucleic Acid Conformation
  • Oligonucleotides*

Substances

  • Oligonucleotides
  • DNA